Overview :
Researchers developed SHetA2, an oral therapy that stops HPV from turning cancerous. It targets three human proteins – mortalin, hsc70, and Grp78 – breaking the HPV-E7 protein connection. This destroys harmful proteins through the body's immune defences. The pill treats precancerous cervical lesions.
The Discovery
Scientists recently developed a promising new therapy for cervical cancer. SHetA2 is an oral pill that stops Human Papillomavirus from causing cancer. This breakthrough offers hope for millions affected by HPV worldwide. The therapy targets HPV-induced cervical dysplasia and cervical cancer specifically.
What is SHetA2 Therapy?
SHetA2 is a small molecule therapy. Scientists design these compounds chemically. They have low molecular weight. This makes them easy for the body to absorb. The therapy comes in capsule form. Researchers have evaluated it as an oral treatment. This makes it convenient for patients.
How It Works
The therapy targets three specific proteins in the human body. These proteins are mortalin, heat shock cognate (hsc70), and glucose regulated protein 78 (Grp78). They are essential for the cancer-causing oncoprotein of the virus to multiply. SHetA2 breaks the connection between the HPV-E7 protein and a host protein inside human cells.
Normally, this host protein protects E7. It allows E7 to keep damaging healthy cells. When SHetA2 breaks this connection, the harmful E7 protein gets destroyed. The body's normal immune defences do this job. This mechanism prevents the virus from turning cells cancerous.
Who Can Benefit?
The therapy targets patients who have developed precancerous lesions of cervical cancer. This is a crucial stage. Treating lesions before they become cancerous saves lives. The oral capsule form makes treatment accessible. Patients don't need hospital visits for injections or infusions.
Understanding HPV
Human Papillomavirus is the most common sexually transmitted infection. More than 100 types of HPV exist. Some types cause skin growths called warts. Other types can cause cancer. About 80% of people – both men and women – will get an HPV infection at some point in their lives. Transmission happens through skin-to-skin contact. Most people get genital HPV through sexual contact including vaginal, anal, and oral sex.
Symptoms and Treatment
Symptoms may include warts on the genitals or anus. Cancerous growths can appear in the mouth or throat. There is no cure for HPV currently. HPV vaccination remains the most effective way to prevent HPV-related cancers. The SHetA2 therapy offers a new treatment approach for those already infected.
What This Means for Public Health
Cervical cancer affects millions of women globally. India carries a significant burden of this disease. SHetA2 offers hope for reducing this burden. Early intervention with oral therapy could prevent cancer development. This could save lives and reduce healthcare costs.
Exam-Focused Points:
-
SHetA2 is a small molecule therapy for HPV-induced cervical dysplasia and cervical cancer.
-
It comes in oral capsule form – easy to administer.
-
Targets three proteins: mortalin, hsc70, and Grp78 .
-
Breaks the connection between HPV-E7 protein and host protein.
-
This allows the body's immune system to destroy the harmful E7 protein .
-
HPV is the most common STI, with over 100 types, and no cure exists currently.
-
HPV vaccination is the most effective prevention method against HPV-related cancers.
FAQs:
Q1. What is SHetA2 therapy?
SHetA2 is an oral small molecule therapy that stops HPV from causing cervical cancer by breaking the HPV-E7 protein connection.
Q2. How does SHetA2 work in the body?
It breaks the connection between the HPV-E7 protein and a host protein, allowing the body's immune system to destroy the harmful E7 protein.
Q3. What proteins does SHetA2 target?
It targets mortalin, heat shock cognate (hsc70), and glucose regulated protein 78 (Grp78).
Q4. Who can benefit from SHetA2 therapy?
Patients with precancerous cervical lesions caused by HPV can benefit from this oral therapy.
Q5. What is the most effective way to prevent HPV-related cancers?
HPV vaccination is the most effective prevention method against HPV-related cancers.